News

Filter

Topic: Neurology Department

January 17, 2025
Brains of people with sickle cell disease appear older
Study also finds socioeconomic status linked to brain health in adults.
News Release
December 17, 2024
NIH grant funds study of cerebral small vessel disease
Research will look for early warning signs, potential treatment of second-leading cause of dementia.
News Release
August 23, 2024
Multiple sclerosis appears to protect against Alzheimer’s disease
Findings could point to new strategies to treat Alzheimer’s.
News Release
July 30, 2024
Accuracy of diagnostic blood tests for Alzheimer’s disease varies
Head-to-head comparison of 6 tests reveals which ones could replace spinal taps, brain scans.
News Release
July 17, 2024
Psilocybin generates psychedelic experience by disrupting brain network
Study advances efforts to harness drug's mind-altering power to treat mental illness.
News Release
July 11, 2024
Disparidades raciales en la demencia estan determinadas por factores sociales
Un estudio confirma que las diferencias raciales en la función cognitiva no se deben a diferencias en el origen genético.
News Release
July 11, 2024
Racial disparities in dementia determined by social factors
Study indicates racial differences in cognitive function not due to genetic ancestry.
News Release
June 17, 2024
Repurposed drug may help stabilize vision in rare disease
Clinical trial for RVCL-S patients tests drug already approved as sickle cell disease treatment.
News Release
June 5, 2024
Holtzman, Chen recognized for exceptional Alzheimer’s research
Morby prize from Cure Alzheimer’s Fund honors discovery of T cells’ role in neurodegeneration.
National Leaders
May 22, 2024
Subtle cognitive decline precedes end to driving for older adults
Routine cognitive testing may help older drivers plan for life after driving.
News Release
April 16, 2024
Alzheimer’s disease progresses faster in people with Down syndrome
Study highlights need to develop therapies for this vulnerable population.
News Release
April 15, 2024
Epilepsy drug prevents brain tumors in mice with NF1
Study lays groundwork for clinical trial aimed at preventing brain tumors in children with NF1.
News Release
April 4, 2024
CPAP replacement works well for the overweight, not obese, study finds
Source: CNN
April 4, 2024
Nerve stimulation for sleep apnea is less effective for people with higher BMIs
Popular alternative to CPAP machines may not be appropriate for all.
News Release
April 3, 2024
Immunotherapy for Alzheimer’s disease shows promise in mouse study
Antibody mobilizes immune cells to clear amyloid plaques, reducing behavioral abnormalities.
News Release
March 8, 2024
How the mind works: Thinking about thinking
Investigating how the cells, circuits and structures of the brain give rise to the complex mental functions that make us who we are.
Outlook Magazine
February 27, 2024
Shellhaas receives Child Neurology Society’s highest honor
Pediatric neurologist recognized for outstanding teaching, scholarship, service.
National Leaders
February 23, 2024
Human development: Starting out strong
WashU Medicine researchers are leading efforts to understand the factors that influence brain development.
Outlook Magazine
February 23, 2024
Ju named Morriss Professor
Neurologist studies role of sleep in neurodegenerative diseases.
News Release
February 21, 2024
Alzheimer’s blood test performs as well as FDA-approved spinal fluid tests
Could make early Alzheimer’s diagnosis, treatment accessible to more people.
News Release
February 19, 2024
Shellhaas elected to American Epilepsy Society board
Specialist in neonatal seizures will help advance epilepsy research, medical care.
National Leaders
February 14, 2024
Brain tumors: Fighting with targeted tools
To understand and treat brain tumors we have to attack them from different angles, and tailor therapy to each patient.
Outlook Magazine
January 25, 2024
Newly opened Jeffrey T. Fort Neuroscience Research Building dedicated
Celebration signals ‘new era for medical science’.
Medical Campus & Community, Video
January 8, 2024
A ‘unique, indelible impact’: Q&A with Dean Perlmutter
Talent, technologies coalesce to drive revolutionary therapies.
Outlook Magazine